Frequent involvement of chromosome 3p alterations in lung carcinogenesis: Allelotypes of 215 established cell lines at six chromosome 3p loci

Journal of Cellular Biochemistry

Volumn 62, Issue SUPPL. 24, 1996, Pages 198-209

  Buchhagen, Dorothy L ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

allelotypes; chromosome 3p; DNA; heterozygosity; lung cancer

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ALLELE; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CHROMOSOME 3P; DNA DETERMINATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; B LYMPHOCYTE; CELL CULTURE; CELL LINE; CHROMOSOME 3; CHROMOSOME ABERRATION; DRUG EFFECT; EPSTEIN BARR VIRUS; GENETIC MARKER; GENETICS; GENOTYPE; LUNG TUMOR; MESOTHELIOMA; PATHOLOGY; PLEURA TUMOR; POLYMERASE CHAIN REACTION; SMALL CELL CARCINOMA; ULTRASTRUCTURE;

DNA;

ALLELES; B-LYMPHOCYTES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL LINE, TRANSFORMED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; DNA, NEOPLASM; GENETIC MARKERS; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; PLEURAL NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0029847959     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199608)62:2<198::AID-JCB8>3.0.CO;2-N     Document Type: Article

References (46)

1. Klein G (1993): Genes that can antagonize tumor development. FASEB J 7:821-825.
2. Buchhagen DL (1991): Molecular mechanisms in lung pathogenesis. Biochim Biophys Acta 1072:159-176.
3. Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF, Minna JD (1982): Specific chromosome defect associated with human small-cell lung cancer: Deletion 3p(14-23). Science 215:181-182.
4. Whang-Peng J, Bunn PA Jr, Kao-Shan CS, Lee EC, Carney DN, Gazdar A, Minna JD (1982): A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet 6:119-134.
5. Whang-Peng J, Knutsen T, Gazdar A, Steinberg SM, Oie H, Linnoila I, Mulshine J, Nau M, Minna JD (1991): Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer. Genes Chrom Cancer 3:168-188.
6. Lukeis R, Ball D, Irving L, Garson OM, Hasthorpe S (1993): Chromosome abnormalities in non-small cell lung cancer pleural effusions: Cytogenetic indicators of disease subgroups. Genes Chrom Cancer 8:262-269.
7. Brauch H, Johnson B, Hovis J, Yano T, Gazdar A, Pettengill OS, Graziano S, Sorenson GD, Poiesz BJ, Minna J, Linehan M, Zbar B (1987): Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N Engl J Med 317:1109-1113.
8. Kok K, Osinga J, Carritt B, Davis MB, Van der Hout AH, van der Veen AY, Landsvater RM, de Leij LFMH, Berendsen HH, Postmus PE, Poppema S, Buys CHCM (1987): Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature 330:578-581.
9. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY (1987): Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 329:451-454.
10. Yokota J, Wada M, Shimosato Y, Terada M, Sugimura T (1987): Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 84:9252-9256.
11. Johnson BE, Sakaguchi AY, Gazdar AF, Minna JD, Burch D, Marshall A, Naylor SL (1988): Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors. J Clin Invest 82:502-507.
12. Rabbitts P, Douglas J, Daly M, Sundaresan V, Fox B, Haselton P, Wells F, Albertson D, Waters J, Bergh J (1989): Frequency and extent of allelic loss in the short arm of chromosome 3 in nonsmall-cell lung cancer. Genes Chrom Cancer 1:95-105.
13. Weston A, Willey JC, Modali R, Sugimura H, McDowell EM, Resau J, Light B, Haugen A, Mann DL, Trump BF, Harris CC. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci USA 86:5099-5103.
14. Leduc F, Brauch H, Hajj C, Dobrovic A, Kaye F, Gazdar A, Harbour JW, Pettengill OS, Sorenson GD, van den Berg A, Kok K, Campling B, Paquin F, Bradley WEC, Zbar B, Minna J, Buys C, Ayoub J (1989): Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers. Am J Hum Genet 44:282-287.
15. Brauch H, Tory K, Kotler F, Gazdar AF, Pettengill OS, Johnson B, Graziano S, Winton T, Buys CHCM, Sorenson GD, Poiesz BJ, Minna JD, Zbar B (1990): Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer. Genes Chrom Cancer 1:240-246.
16. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, Suyama M, Takagi H, Nakamura Y, Takahashi T (1992): Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 7:445-449.
17. Zbar B, Brauch H, Talmadge C, Linehan M (1987): Loss of alleles on the short arm of chromosome 3 in renal cell carcinoma. Nature 327:721-724.
18. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Muller-Brechlin R, Klein G, Sumegi J (1988): Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 85:1571-1575.
19. Bergerheim U, Nordenskjold M, Collins VP (1989): Deletion mapping in human renal cell carcinoma. Cancer Res 49:1390-1396.
20. Tory K, Brauch H, Linehan M, Barba D, Oldfield E, Filling-Katz M, Seizinger B, Nakamura Y, White R, Marshall FF, Lerman MI, Zbar B (1989): Specific genetic change in tumors associated with von Hippel-Lindau Disease. J Natl Cancer Inst 81:1097-1101.
21. Yokota J, Tsukada YT, Nakajima T, Gotoh M, Shimisato Y, Mori N, Tsunokawa Y, Sugimura T, Terada M (1989): Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 49:3598-3601.
22. Ehlen T, Dubeau L (1990): Loss of heterozygosity on chromosomal segments 3p, 6q, 11p in human ovarian carcinomas. Oncogene 5:219-223.
23. Kohno T, Takayama H, Hamaguchi M, Takano H, Yamaguchi N, Tsuda H, Hirohashi S, Vissing H, Shimizu M, Oshimura M, Yokato J (1993): Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene 8:1825-1832.
24. Ali IU, Liderau R, Callahan R (1989): Presence of two members of c-erbA receptor gene family (c-erbAβ and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma. J Natl Cancer Inst 81:1815-1820.
25. Devilee P, van den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Khan PM, Pearson PL, Cornelisse CJ (1989): At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 5:554-560.
26. Buchhagen DL, Qui L, Etkind P (1994): Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3-3p21.3 in sporadic breast cancer development. Int J Cancer 57:473-479.
27. Latif F, Fivash M, Glenn G, Tory K, Orcutt ML, Hampsch K, Delisio J, Lerman M, Cowan J, Beckett M, Weichselbaum R (1992): Chromosome 3p deletions in head and neck carcinomas: Statistical ascertainment of allelic loss. Cancer Res 52:1451-1456.
28. Buchhagen DL, Worsham MJ, Van Dyke DL, Carey TE: Three discrete regions of chromosome 3p loss in cell lines from squamous cell carcinomas of the head and neck. Genes Chrom Cancer (in press).
29. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehan NM, Rabbitts P (1992): p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7:1989-1997.
30. Ganly P, Jarad N, Rudd RM, Rabbitts PH (1992): PCR-based RFLP analysis allows genotyping of the short arm of chromosome 3 in small biopsies from patients with lung cancer. Genomics 12:221-228.
31. Heppel-Parton AC, Albertson DG, Fishpool R, Rabbitts PH (1994): Multicolor fluorescence in situ hybridisation to order small, single-copy probes on metaphase chromosomes. Cytogenet Cell Genet 66:42-47.
32. Heppell-Parton A, Albertson DG, Rabbitts PH (1992): Ordering of six polymorphic DNA markers important in the delineation of 3p deletions in neoplasia. Genes Chromo Cancer 4:228-234.
33. Naylor S, Carritt B (1991): Report of the committee on the genetic constitution of chromosome 3. Cytogenet Cell Genet 58:170-230.
34. Albertson DG, Sherringham PD, Rabbitts PH (1989): Localisation of polymorphic DNA probes frequently deleted in lung cancer. Hum Genet 83:127-132.
35. Nakamura Y, Culver M, Gillilan S, O'Connell P, Leppert M, Lathrop GM, Lalouel J-M, White R (1987): Isolation and mapping of a polymorphic DNA sequence pYNZ86.1 on chromosome 3 [D3S30]. Nucleic Acids Res 15:10079.
36. Barker D, Schafer M, White R (1984): Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 36:131-138.
37. Fujimoto E, Nakamura Y, Gill J, O'Connell P, Leppert M, Lathrop GM, Lalouel J-M, White R (1988): Isolation and mapping of a polymorphic DNA sequence (pEFD145) on chromosome 3 [D3S32]. Nucleic Acids Res. 16:9357.
38. Middleton PG, De Angelas CL, Weir-Thompson EM, Steel CM (1986): RFLP for the human erbA2 gene. Nucleic Acids Res. RFLP report 14:1925.
39. Johnson BE, Whang-Peng J, Naylor SL, Zbar B, Brauch H, Lee E, Simmons A, Russell E, Nam MH, Gazdar AF (1989): Retention of chromosome 3 Ln extrapulmonary small cell cancer shown by molecular and cytogenetic studies. J Natl Cancer Inst 81:1223-1228.
40. Rabbitts P, Bergh J, Douglas J, Collins F, Waters J (1990): A submicroscopic homozygous deletion at the D3S3 locus in a cell line isolated from a small cell lung carcinoma. Genes Chrom Cancer 2:231-238.
41. Daly MC, Douglas JB, Bleehen NM, Hastleton P, Twentyman PR, Sundaresan V, Carritt B, Bergh J, Rabbitts PH (1991): An unusually proximal deletion on the short arm of chromosome 3 in a patient with small cell lung cancer. Genomics 9:113-119.
42. Yamakawa K, Takahashi T, Horio Y, Murata Y, Takahashi E-i, Hibi K, Yokoyama S, Ueda R, Takahashi T, Nakamura Y (1993): Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22. Oncogene 8:327-330.
43. Daly MC, Xiang R-H, Buchhagen D, Hensel CH, Garcia DK, Killary AM, Minna JD, Naylor SL (1993): A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity. Oncogene 8:1721-1729.
44. Miller YE, Minna JD, Gazdar AF (1989): Lack of expression of aminoacylase-1 in small cell lung cancer: Evidence for inactivation of genes encoded by chromosome 3p. J Clin Invest 83:2120-2124.
45. LaForgia S, Morse B, Levy J, Barnea G, Cannizzaro LA, Li F, Nowell PC, Boghosian-Sell L, Glick J, Weston A, Harris CC, Drabkin H, Patterson D, Croce CM, Schlessinger J, Huebner K (1991): Receptor protein-tyrosine phosphatase γ is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci USA 88:5036-5040.
46. Doyle LA, Giangiulo D, Hussain A, Park HJ, Yen R-WC, Borges M (1989): Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid. Cancer Res 49:6745-6751.